Biomerieux SA
PAR:BIM

Watchlist Manager
Biomerieux SA Logo
Biomerieux SA
PAR:BIM
Watchlist
Price: 102.9 EUR 0.39%
Market Cap: 12.1B EUR
Have any thoughts about
Biomerieux SA?
Write Note

Wall Street
Price Targets

BIM Price Targets Summary
Biomerieux SA

Wall Street analysts forecast BIM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIM is 120.69 EUR with a low forecast of 90.9 EUR and a high forecast of 135.45 EUR.

Lowest
Price Target
90.9 EUR
12% Downside
Average
Price Target
120.69 EUR
17% Upside
Highest
Price Target
135.45 EUR
32% Upside
Biomerieux SA Competitors:
Price Targets
9996
Peijia Medical Ltd
31% Upside
688617
APT Medical Inc
10% Upside
2235
MicroTech Medical Hangzhou Co Ltd
9% Upside
STIL
Stille AB
24% Upside
AXNX
Axonics Inc
4% Upside
7716
Nakanishi Inc
18% Upside
DCTH
Delcath Systems Inc
102% Upside
IPD
ImpediMed Ltd
188% Upside

Revenue
Forecast

Revenue Estimate
Biomerieux SA

For the last 8 years the compound annual growth rate for Biomerieux SA's revenue is 8%. The projected CAGR for the next 3 years is 8%.

8%
Past Growth
8%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Biomerieux SA

For the last 8 years the compound annual growth rate for Biomerieux SA's operating income is 9%. The projected CAGR for the next 3 years is 21%.

9%
Past Growth
21%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Biomerieux SA

For the last 8 years the compound annual growth rate for Biomerieux SA's net income is 16%. The projected CAGR for the next 3 years is 20%.

16%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIM's stock price target?
Price Target
120.69 EUR

According to Wall Street analysts, the average 1-year price target for BIM is 120.69 EUR with a low forecast of 90.9 EUR and a high forecast of 135.45 EUR.

What is Biomerieux SA's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Biomerieux SA's revenue is 8%. The projected CAGR for the next 3 years is 8%.

What is Biomerieux SA's Operating Income forecast?
Projected CAGR
21%

For the last 8 years the compound annual growth rate for Biomerieux SA's operating income is 9%. The projected CAGR for the next 3 years is 21%.

What is Biomerieux SA's Net Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Biomerieux SA's net income is 16%. The projected CAGR for the next 3 years is 20%.

Back to Top